Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review
Background: Glycogen-rich clear cell breast carcinoma is a rare histological breast cancer subtype. Its prognosis may vary depending on specific clinical and pathological characteristics such as low grade, strong positivity of estrogen receptor (ER) expression and early diagnosis. Case Presentation:...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2015-11-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/441838 |
id |
doaj-59404d1124cb4dc79f9287d3c6793f30 |
---|---|
record_format |
Article |
spelling |
doaj-59404d1124cb4dc79f9287d3c6793f302020-11-24T22:35:03ZengKarger PublishersCase Reports in Oncology1662-65752015-11-018347247710.1159/000441838441838Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature ReviewVilma RattiOlivia PaganiBackground: Glycogen-rich clear cell breast carcinoma is a rare histological breast cancer subtype. Its prognosis may vary depending on specific clinical and pathological characteristics such as low grade, strong positivity of estrogen receptor (ER) expression and early diagnosis. Case Presentation: We present the case of a 53-year-old woman with a bleeding 10-cm-diameter mass in the left breast. The histological examination showed a poorly differentiated tumor with malignant cells characterized by abundant clear cytoplasm. The diagnosis of clear cell carcinoma was based on the histological characteristics of the tumor, and a nonmammary origin was initially ruled out. The tumor was triple negative [i.e. ER, progesterone receptor (PR) and HER2 negative]. Four months after the initial locoregional treatment, the patient developed lung and distant lymph node metastases. Conclusions: Glycogen-rich clear cell carcinoma of the breast is a rare tumor. Early diagnosis, absence of lymph node metastases and ER/PR positivity are associated with a better prognosis, as in other common breast cancer subtypes.http://www.karger.com/Article/FullText/441838Breast cancerGlycogen-rich clear cell carcinoma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vilma Ratti Olivia Pagani |
spellingShingle |
Vilma Ratti Olivia Pagani Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review Case Reports in Oncology Breast cancer Glycogen-rich clear cell carcinoma |
author_facet |
Vilma Ratti Olivia Pagani |
author_sort |
Vilma Ratti |
title |
Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review |
title_short |
Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review |
title_full |
Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review |
title_fullStr |
Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review |
title_full_unstemmed |
Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review |
title_sort |
clear cell carcinoma of the breast: a rare breast cancer subtype - case report and literature review |
publisher |
Karger Publishers |
series |
Case Reports in Oncology |
issn |
1662-6575 |
publishDate |
2015-11-01 |
description |
Background: Glycogen-rich clear cell breast carcinoma is a rare histological breast cancer subtype. Its prognosis may vary depending on specific clinical and pathological characteristics such as low grade, strong positivity of estrogen receptor (ER) expression and early diagnosis. Case Presentation: We present the case of a 53-year-old woman with a bleeding 10-cm-diameter mass in the left breast. The histological examination showed a poorly differentiated tumor with malignant cells characterized by abundant clear cytoplasm. The diagnosis of clear cell carcinoma was based on the histological characteristics of the tumor, and a nonmammary origin was initially ruled out. The tumor was triple negative [i.e. ER, progesterone receptor (PR) and HER2 negative]. Four months after the initial locoregional treatment, the patient developed lung and distant lymph node metastases. Conclusions: Glycogen-rich clear cell carcinoma of the breast is a rare tumor. Early diagnosis, absence of lymph node metastases and ER/PR positivity are associated with a better prognosis, as in other common breast cancer subtypes. |
topic |
Breast cancer Glycogen-rich clear cell carcinoma |
url |
http://www.karger.com/Article/FullText/441838 |
work_keys_str_mv |
AT vilmaratti clearcellcarcinomaofthebreastararebreastcancersubtypecasereportandliteraturereview AT oliviapagani clearcellcarcinomaofthebreastararebreastcancersubtypecasereportandliteraturereview |
_version_ |
1725724983735353344 |